• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Klaria Pharma Holding AB: Annula Genernal Meeting Date Change:  Klaria Pharma Holding (publ)

Klaria Pharma Holding
Read the release

Due to the change of auditor in Klaria Holding AB, the board has decided to move the date of the annual general meeting to 26 May 2026 at 10:00 and the publication of the 2025 annual report to 5 May 2026.

The reason for the change of auditor from BDO Sweden to Azets Revision och Rådgivning AB was to avoid a conflict of interest with the business development assignment that BDO LLP's UK Life Sciences M&A is performing together with Klaria. To give Azets the opportunity to carry out the audit without excessive time pressure, the board has decided to change the date of the 2025 annual general meeting.

Board of Directors

Klaria Pharma Holding